• Wed news: Novo and Viking heat up MASH space. New Pfizer R&D chief. Trump and the Biosecure Act. Sage Huntington’s prospect flunks trial. Dr. Oz to run CMS. See more on our front page

ImmunityBio

Details or it didn't happen
Don't need to worry about convincing feeble minds.
The show is over.
Immunity cut 70% of market access and sales. Only a few people were given offers at ImmunityBio.
Sales are in the basement and Matt Hilman is threatening reps. Thats after he's done golfing.
This is a dumpster fire people. Look to Adstiladrin.
 




Yeah he’s currently on the golf course in Hawaii. What a loser. He thinks he has pulled the wool over Rich’s eyes. $0 in October. Coincidence Rich?
ImmunityBio keeps changing the sales organization, but upper management leadership cares deeply about the stock price and sales, and without sales reps and with a sales leader that is unpleasant to work with, sales will not be soaring and customers will be cautious about why there has been yet another dramatic change.
There were no organized clinical education events for Urologists at the Hawaii meeting, which does not translate into increased sales. The stock market will reflect what they think of the company's prospects when they receive the next market update, and that is something that the CEO will care about. ImmunityBio is cash poor until they get another cash infusion or sales increase. Any additional indications for the product are not being approved anytime soon.
 












Don't need to worry about convincing feeble minds.
The show is over.
Immunity cut 70% of market access and sales. Only a few people were given offers at ImmunityBio.
Sales are in the basement and Matt Hilman is threatening reps. Thats after he's done golfing.
This is a dumpster fire people. Look to Adstiladrin.
Matt Hilman needs his pink slip on Monday. Its over people.
 
















  • HOMEYG   Nov 13, 2024 at 03:05: PM
I immediately withdrew from the interview process after reading this. I’ll stay in big pharma. Good lord. I think Purdue pharma with OxyContin has better reviews than this place…..
 




I immediately withdrew from the interview process after reading this. I’ll stay in big pharma. Good lord. I think Purdue pharma with OxyContin has better reviews than this place…..
Matt Hilman is a total D-Bag. No one wants to speak with, or work with the guy. He literally has pissed off everyone. Every rep currently employed is in 2nd to 3rd round interviews to leave this company. Everyone is jumping and pulling the parachute cord. This place is a sinking ship. Rich & Matt think thats its going to skyrocket in Jan when we get our code. The only thing that will skyrocket will be the amount of resignations on Rich's desk. ImmunityBio is going to get destroyed by Janssen and CG Oncology. The culture is terrible at ImmunityBio. Stay away from this place at all costs.
 




  • HOMEYG   Nov 13, 2024 at 06:17: PM
Matt Hilman is a total D-Bag. No one wants to speak with, or work with the guy. He literally has pissed off everyone. Every rep currently employed is in 2nd to 3rd round interviews to leave this company. Everyone is jumping and pulling the parachute cord. This place is a sinking ship. Rich & Matt think thats its going to skyrocket in Jan when we get our code. The only thing that will skyrocket will be the amount of resignations on Rich's desk. ImmunityBio is going to get destroyed by Janssen and CG Oncology. The culture is terrible at ImmunityBio. Stay away from this place at all costs.
I’m from j&j. I’ll check out their oncology openings. Thanks :)
 












Hilman telling the band-aid sales force that we need to hit $10 million by end of 2024. Truth is that everyone is interviewing and no one is selling. The lights will get turned off in about 90 days. F Y Matty!
Dear Rich Adcock,

Hilman is a huge jackass who commands zero respect, You need to fire him now or we are all leaving!